QIU Luan, ZHANG Xinyue, LI Jianxiong. Status quo and prospect of hepatocellular carcinoma therapy[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2017, 38(9): 886-889. DOI: 10.3969/j.issn.2095-5227.2017.09.022
Citation:
QIU Luan, ZHANG Xinyue, LI Jianxiong. Status quo and prospect of hepatocellular carcinoma therapy[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2017, 38(9): 886-889. DOI: 10.3969/j.issn.2095-5227.2017.09.022
QIU Luan, ZHANG Xinyue, LI Jianxiong. Status quo and prospect of hepatocellular carcinoma therapy[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2017, 38(9): 886-889. DOI: 10.3969/j.issn.2095-5227.2017.09.022
Citation:
QIU Luan, ZHANG Xinyue, LI Jianxiong. Status quo and prospect of hepatocellular carcinoma therapy[J]. ACADEMIC JOURNAL OF CHINESE PLA MEDICAL SCHOOL, 2017, 38(9): 886-889. DOI: 10.3969/j.issn.2095-5227.2017.09.022
Status quo and prospect of hepatocellular carcinoma therapy
Hepatocellular carcinoma (HCC) is a common cancer with high incidence and mortality worldwide． Local advance or distant metastasis of HCC results in difficult treatment and poor prognosis． This article reviews the current treatments of HCC and their indications and contraindications, analyzes the advantages and disadvantages of different treatment methods, which may provide evidences for clinical practive．
DownLoad: